Biotest Aktiengesellschaft (BIO.DE)
EUR 41.4
(0.49%)
EUR 41.4
(0.49%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 419.1 Million EUR | 42.65% |
| 2022 | 293.8 Million EUR | 20.11% |
| 2021 | 244.6 Million EUR | -15.68% |
| 2020 | 290.1 Million EUR | 3.57% |
| 2019 | 280.1 Million EUR | 34.47% |
| 2018 | 208.3 Million EUR | 41.8% |
| 2017 | 146.9 Million EUR | -13.99% |
| 2016 | 170.8 Million EUR | -21.9% |
| 2015 | 218.7 Million EUR | -11.1% |
| 2014 | 246 Million EUR | 8.37% |
| 2013 | 227 Million EUR | 23.22% |
| 2012 | 184.21 Million EUR | 20.42% |
| 2011 | 152.98 Million EUR | 2.87% |
| 2010 | 148.71 Million EUR | -12.69% |
| 2009 | 170.32 Million EUR | 8.8% |
| 2008 | 156.55 Million EUR | 33.95% |
| 2007 | 116.87 Million EUR | 11.57% |
| 2006 | 104.75 Million EUR | -3.33% |
| 2005 | 108.36 Million EUR | -7.12% |
| 2004 | 116.66 Million EUR | -0.48% |
| 2003 | 117.22 Million EUR | -9.76% |
| 2002 | 129.89 Million EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 438.7 Million EUR | 4.68% |
| 2024 Q2 | 472.5 Million EUR | 7.7% |
| 2023 Q2 | 341.1 Million EUR | 4.12% |
| 2023 FY | 419.1 Million EUR | 42.65% |
| 2023 Q4 | 419.1 Million EUR | 12.18% |
| 2023 Q3 | 373.6 Million EUR | 9.53% |
| 2023 Q1 | 327.6 Million EUR | 11.5% |
| 2022 Q1 | 255.8 Million EUR | 4.58% |
| 2022 FY | 293.8 Million EUR | 20.11% |
| 2022 Q4 | 293.8 Million EUR | 9.34% |
| 2022 Q3 | 268.7 Million EUR | 2.09% |
| 2022 Q2 | 263.2 Million EUR | 2.89% |
| 2021 Q3 | 298.1 Million EUR | -1.65% |
| 2021 Q2 | 303.1 Million EUR | 0.43% |
| 2021 Q1 | 301.8 Million EUR | 4.03% |
| 2021 Q4 | 244.6 Million EUR | -17.95% |
| 2021 FY | 244.6 Million EUR | -15.68% |
| 2020 Q3 | 306.9 Million EUR | 0.85% |
| 2020 FY | 290.1 Million EUR | 3.57% |
| 2020 Q1 | 312.4 Million EUR | 11.53% |
| 2020 Q4 | 290.1 Million EUR | -5.47% |
| 2020 Q2 | 304.3 Million EUR | -2.59% |
| 2019 Q4 | 280.1 Million EUR | 8.86% |
| 2019 Q2 | 247 Million EUR | 4.66% |
| 2019 Q3 | 257.3 Million EUR | 4.17% |
| 2019 FY | 280.1 Million EUR | 34.47% |
| 2019 Q1 | 236 Million EUR | 13.3% |
| 2018 FY | 208.3 Million EUR | 41.8% |
| 2018 Q4 | 208.3 Million EUR | 15.98% |
| 2018 Q3 | 179.6 Million EUR | 8.19% |
| 2018 Q2 | 166 Million EUR | 0.55% |
| 2018 Q1 | 165.1 Million EUR | 12.39% |
| 2017 FY | 146.9 Million EUR | -13.99% |
| 2017 Q4 | 146.9 Million EUR | -13.54% |
| 2017 Q3 | 169.9 Million EUR | -0.47% |
| 2017 Q2 | 170.7 Million EUR | 2.09% |
| 2017 Q1 | 167.2 Million EUR | -2.11% |
| 2016 Q1 | 208.3 Million EUR | -4.76% |
| 2016 FY | 170.8 Million EUR | -21.9% |
| 2016 Q4 | 170.8 Million EUR | -8.57% |
| 2016 Q3 | 186.8 Million EUR | -8.07% |
| 2016 Q2 | 203.2 Million EUR | -2.45% |
| 2015 Q4 | 218.7 Million EUR | -3.27% |
| 2015 FY | 218.7 Million EUR | -11.1% |
| 2015 Q1 | 251.6 Million EUR | 2.28% |
| 2015 Q2 | 243.6 Million EUR | -3.18% |
| 2015 Q3 | 226.1 Million EUR | -7.18% |
| 2014 Q2 | 263.7 Million EUR | 6.76% |
| 2014 FY | 246 Million EUR | 8.37% |
| 2014 Q4 | 246 Million EUR | -8.04% |
| 2014 Q3 | 267.5 Million EUR | 1.44% |
| 2014 Q1 | 247 Million EUR | 8.81% |
| 2013 Q2 | 210.8 Million EUR | 8.66% |
| 2013 Q3 | 223 Million EUR | 5.79% |
| 2013 Q4 | 227 Million EUR | 1.79% |
| 2013 FY | 227 Million EUR | 23.22% |
| 2013 Q1 | 194 Million EUR | 5.31% |
| 2012 Q3 | 177.5 Million EUR | -0.11% |
| 2012 Q4 | 184.21 Million EUR | 3.78% |
| 2012 FY | 184.21 Million EUR | 20.42% |
| 2012 Q1 | 167.7 Million EUR | 9.62% |
| 2012 Q2 | 177.7 Million EUR | 5.96% |
| 2011 Q2 | 145.8 Million EUR | 0.48% |
| 2011 FY | 152.98 Million EUR | 2.87% |
| 2011 Q3 | 160.2 Million EUR | 9.88% |
| 2011 Q4 | 152.98 Million EUR | -4.5% |
| 2011 Q1 | 145.1 Million EUR | -2.43% |
| 2010 Q4 | 148.71 Million EUR | -11.43% |
| 2010 FY | 148.71 Million EUR | -12.69% |
| 2010 Q3 | 167.9 Million EUR | -1.47% |
| 2010 Q2 | 170.4 Million EUR | 1.43% |
| 2010 Q1 | 168 Million EUR | -1.37% |
| 2009 FY | 170.32 Million EUR | 8.8% |
| 2009 Q4 | 170.32 Million EUR | 0.0% |
| 2008 FY | 156.55 Million EUR | 33.95% |
| 2007 FY | 116.87 Million EUR | 11.57% |
| 2006 FY | 104.75 Million EUR | -3.33% |
| 2005 FY | 108.36 Million EUR | -7.12% |
| 2004 FY | 116.66 Million EUR | -0.48% |
| 2003 FY | 117.22 Million EUR | -9.76% |
| 2002 FY | 129.89 Million EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| BioNTech SE | 357.7 Million EUR | -17.165% |
| CureVac N.V. | 24.82 Million EUR | -1588.459% |
| Biotest Aktiengesellschaft | 419.1 Million EUR | 0.0% |
| BRAIN Biotech AG | 9.72 Million EUR | -4209.068% |
| Formycon AG | 467 Thousand EUR | -89643.041% |
| Heidelberg Pharma AG | 10.48 Million EUR | -3896.075% |
| Medigene AG | 1.00 EUR | -41909999900.0% |